Dose-dependent targeting of 89Zr-labeled atezolizumab (anti-PD-L1 antibody) to PD-L1 expressing tumor xenografts

被引：0
|
作者：
Longtine, Mark [1 ]
Wahl, Richard [1 ]
机构：
[1] Mallinckrodt Inst Radiol, St Louis, MO USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1105
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeted Non-Invasive PET Imaging of PD-L1-Expressing Colon Cancer Using a Zirconium-89 Radiolabeled Anti-PD-L1 Antibody
    Mulgaonkar, Aditi
    Hao, Guiyang
    Xiong, Yahong
    Tang, Haidong
    Nham, Kien
    Silvers, William
    Fu, Yang-Xin
    Sun, Xiankai
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [42] Suppression of Endometriosis Using Anti-PD-L1 Antibody
    Mamillapalli, Ramanaiah
    Gawde, Nimisha
    Ucar, Abdullah
    Taylor, Hugh S.
    REPRODUCTIVE SCIENCES, 2023, 30 : 198A - 199A
  • [43] Product review: avelumab, an anti-PD-L1 antibody
    Collins, Julie M.
    Gulley, James L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 891 - 908
  • [44] 89Zr-Df-anti-PD-L1 for evaluating in vivo PD-L1 level in lung cancer mouse model
    Geller, Anne
    Yan, Jun
    Guo, Haixun
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [45] Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
    Park, Ji-Eun
    Kim, Seong-Eun
    Keam, Bhumsuk
    Park, Ha-Ram
    Kim, Soyeon
    Kim, Miso
    Kim, Tae Min
    Doh, Junsang
    Kim, Dong-Wan
    Heo, Dae Seog
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [46] Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Knapp, Deborah W.
    Lim, Seung-Oe
    MOLECULAR THERAPY, 2025, 33 (02)
  • [47] Immuno-PET imaging of 89Zr labeled anti-PD-L1domain antibody
    Li, Dan
    Cheng, Siyuan
    Zhu, Xiao-Hua
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [48] Dynamic Changes of Plasma PD-L1 mRNA Expression Predict Response to Anti-PD-1/Anti-PD-L1 Treatment in Malignancies
    Sun, J.
    Yang, Q.
    Chen, M.
    Gu, J.
    Zheng, L.
    Yu, Y.
    Li, F.
    Zhang, L.
    Niu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S451 - S451
  • [49] Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types
    Kim, Joseph W.
    Eder, Joseph Paul
    ONCOLOGY-NEW YORK, 2014, 28 : 15 - 28
  • [50] Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
    Liu, Kefang
    Tan, Shuguang
    Chai, Yan
    Chen, Danqing
    Song, Hao
    Zhang, Catherine Wei-Hong
    Shi, Yi
    Liu, Jun
    Tan, Wenjie
    Lyu, Jianxin
    Gao, Shan
    Yan, Jinghua
    Qi, Jianxun
    Gao, George F.
    CELL RESEARCH, 2017, 27 (01) : 151 - 153
12345